BfR Highlights Traditional Kratom Use, Implications for Industry Due to Psychoactive Properties

The German Federal Institute for Risk Assessment (BfR) has recently shed light on the long-standing traditional uses of Kratom, derived from the leaves of the Mitragyna speciosa tree. For centuries, this plant has been a staple in Southeast Asian traditional medicine, where it has been employed for a range of purposes, including alleviating pain and enhancing overall performance.

For manufacturers like us at Supplement Factory, and indeed for brand owners navigating the intricate European market, this information from a prominent regulatory body like the BfR is highly significant. While Kratom’s historical applications are intriguing, its classification and potential for inclusion in food supplements in the EU are complex. The BfR's mention underscores the need for extreme caution and a thorough understanding of an ingredient's pharmacological profile before any consideration in product development.

Regulatory Realities for Novel Botanicals

The challenge with botanicals like Kratom lies in their active compounds. The leaves contain alkaloids, notably mitragynine and 7-hydroxymitragynine, which are known to interact with opioid receptors in the brain. This interaction is the basis of Kratom's reported psychoactive and pain-relieving effects. Therefore, from a regulatory standpoint, particularly within the stringent confines of the Novel Food Regulation (EC) No 2015/2283 in the EU, an ingredient with such properties faces immense scrutiny.

“Understanding the pharmacological activity of traditional botanicals is paramount. As an industry, we must always balance historical use cases with contemporary scientific safety data and robust regulatory compliance.” - Supplement Factory Editorial Team

Brand owners considering novel ingredients must ensure they have comprehensive data on toxicology, efficacy, and potential side effects. The presence of psychoactive properties typically positions an ingredient outside the scope of conventional food supplements due to public health concerns and potential for misuse. This is why thorough due diligence is not just good practice, but a critical regulatory imperative.

Consumer Demand and Ethical Sourcing

Despite regulatory hurdles, there's a growing consumer interest in traditional remedies and botanicals, often fuelled by information available online. Manufacturers therefore have a dual responsibility: to innovate safely and to educate. When engaging with raw material suppliers, especially for botanicals originating from traditional medicine systems, it is vital to inquire about sustainable and ethical sourcing practices, as well as robust quality control to confirm identity and purity.

The BfR's acknowledgement of Kratom's traditional uses serves as a timely reminder that while new product development may sometimes look to historical precedents, the path to market for such ingredients in highly regulated environments like Europe is paved with stringent scientific assessment and regulatory compliance.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.